Personalization of Clotting Factor VIII Replacement Therapy Based on Population Pharmacokinetics in Adult Patients with Severe Hemophilia a Who Frequently Switch Factor VIII Concentrates

被引:0
|
作者
Windyga, Jerzy [1 ]
Odnoczko, Edyta [2 ]
Stefanska-Windyga, Ewa [3 ]
Baran, Beata [2 ]
Sikorska, Anna [3 ]
Gorska-Kosicka, Magdalena [4 ]
Zawilski, Janusz [5 ]
Letowska, Magdalena [6 ]
机构
[1] Inst Hematol & Transfus Med, Dept Hemostasis Disorders & Internal Med, Lab Hemostasis & Metab Dis, Warsaw, Poland
[2] Inst Hematol & Transfus Med, Lab Hemostasis & Metab Dis, Warsaw, Poland
[3] Inst Hematol & Transfus Med, Clin Hemostasis Disorders, Warsaw, Poland
[4] Inst Hematol & Transfus Med, Dept Hemostasis Disorders & Internal Med, Warsaw, Poland
[5] INTERLAB, Poznan, Poland
[6] Inst Hematol & Transfus Med, Dept Transfus Med, Warsaw, Poland
关键词
D O I
10.1182/blood-2022-164998
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:8451 / 8452
页数:2
相关论文
共 50 条
  • [21] Factor VIII pharmacokinetics associates with genetic modifiers of VWF and FVIII clearance in an adult hemophilia A population
    Ogiwara, Kenichi
    Swystun, Laura L.
    Paine, A. Simonne
    Kepa, Sylvia
    Choi, Seon Jai
    Rejto, Judit
    Hopman, Wilma
    Pabinger, Ingrid
    Lillicrap, David
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (03) : 654 - 663
  • [22] Should hemophilia treaters switch to albumin-free recombinant factor VIII concentrates
    Meeks, Shannon L.
    Josephson, Cassandra D.
    CURRENT OPINION IN HEMATOLOGY, 2006, 13 (06) : 457 - 461
  • [23] The Asialoglycoprotein Receptor Minor Subunit Gene Contributes to Pharmacokinetics of Factor VIII Concentrates in Hemophilia A
    Lunghi, Barbara
    Morfini, Massimo
    Martinelli, Nicola
    Balestra, Dario
    Linari, Silvia
    Frusconi, Sabrina
    Branchini, Alessio
    Cervellera, Christian F.
    Marchetti, Giovanna
    Castaman, Giancarlo
    Bernardi, Francesco
    THROMBOSIS AND HAEMOSTASIS, 2022, 122 (05) : 715 - 725
  • [24] Inversions of the factor VIII gene in Japanese patients with severe hemophilia A
    Fukuda, K
    Naka, H
    Morichika, S
    Shibata, M
    Tanaka, I
    Shima, M
    Yoshioka, A
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 79 (03) : 303 - 306
  • [25] IMMUNE-COMPLEX ANALYSIS IN PATIENTS WITH SEVERE HEMOPHILIA-A DURING FACTOR-VIII REPLACEMENT THERAPY
    KORHOLZ, D
    WAHN, V
    VONKRIES, R
    FABRY, U
    GOBEL, U
    KLINISCHE PADIATRIE, 1986, 198 (04): : 306 - 311
  • [26] Factor VIII inhibitors in patients with non-severe hemophilia
    Kempton, C. L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 78 - 79
  • [27] Inversions of the Factor VIII Gene in Japanese Patients with Severe Hemophilia A
    Kazuyoshi Fukuda
    Hiroyuki Naka
    Shogo Morichika
    Masaru Shibata
    Ichiro Tanaka
    Midori Shima
    Akira Yoshioka
    International Journal of Hematology, 2004, 79 : 303 - 306
  • [28] Mutation analysis of factor VIII in Korean patients with severe hemophilia A
    Chur-Woo You
    Hee-Sook Son
    Hee Jin Kim
    Eui-Jeon Woo
    Soon-Ae Kim
    Haing-Woon Baik
    International Journal of Hematology, 2010, 91 : 784 - 791
  • [29] Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A
    Goudemand, J
    Rothschild, C
    Demiguel, V
    Vinciguerrat, C
    Lambert, T
    Chambost, H
    Borel-Derlon, A
    Claeyssens, S
    Laurian, Y
    Calvez, T
    BLOOD, 2006, 107 (01) : 46 - 51
  • [30] Mutation analysis of factor VIII in Korean patients with severe hemophilia A
    You, Chur-Woo
    Son, Hee-Sook
    Kim, Hee Jin
    Woo, Eui-Jeon
    Kim, Soon-Ae
    Baik, Haing-Woon
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (05) : 784 - 791